calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,414 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,414 8k filing · 2,000 device pma
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: COSETTE. Form: JELLY. Route: TOPICAL
Sponsor: ASPEN. Form: TABLET. Route: ORAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: SPRAY, METERED. Route: NASAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: DR REDDYS. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: GENUS. Form: SYRUP. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION
Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: SPRAY, METERED. Route: NASAL